Long-term Outcomes of Open Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer in the Prostate-specific Antigen Era

Urology ◽  
2012 ◽  
Vol 79 (3) ◽  
pp. 626-631 ◽  
Author(s):  
Ryan P. Dorin ◽  
Siamak Daneshmand ◽  
Mark A. Lassoff ◽  
Jie Cai ◽  
Donald G. Skinner ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
Radical Retropubic Prostatectomy ◽  
Localized Prostate Cancer ◽  
Long Term Outcomes ◽  
Retropubic Prostatectomy

scholarly journals Stage T2 prostate cancer presented with high serum prostate specific antigen and nonspecific bone lesions

2007 ◽  
Vol 54 (4) ◽  
pp. 109-112 ◽  
Author(s):  
T. Pejcic ◽  
J. Hadzi-Djokic ◽  
B.B. Markovic ◽  
H.M. Maksimovic ◽  
M. Acimovic ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
High Serum ◽  
Radical Retropubic Prostatectomy ◽  
Bone Lesions ◽  
Gleason Grade ◽  
Retropubic Prostatectomy ◽  
Pathological Conditions ◽  
Tissue Production

Objective: To present the case of T2 prostate cancer (PCa) mimicking disseminated PCa that was successfully treated with radical retropubic prostatectomy (RRP). Patient and the method: The patient had prostate specific antigen (PSA) level higher than 30ng/ml and multiple atypical lesions on bone scan. TRUS guided biopsy proved small PCa, only in 1/18 biopsy cores, with Gleason grade 6 (3+3). Bone lesions appeared to be posttraumatic. Result: The patient underwent RRP; six months after surgery there is no evidence of the disease. Conclusion: Serum PSA level is the sum of cancer activity, normal and BHP tissue production, as well as the result of other pathological conditions, like prostatitis. In some cases, inflammation can be responsible for high PSA level and over-staging.

Sign in / Sign up

Export Citation Format

Share Document